BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16787407)

  • 1. RS-alpha-lipoic acid protects cholinergic cells against sodium nitroprusside and amyloid-beta neurotoxicity through restoration of acetyl-CoA level.
    Bielarczyk H; Gul S; Ronowska A; Bizon-Zygmanska D; Pawelczyk T; Szutowicz A
    J Neurochem; 2006 Aug; 98(4):1242-51. PubMed ID: 16787407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NGF on acetylcholine, acetyl-CoA metabolism, and viability of differentiated and non-differentiated cholinergic neuroblastoma cells.
    Szutowicz A; Madziar B; Pawełczyk T; Tomaszewicz M; Bielarczyk H
    J Neurochem; 2004 Aug; 90(4):952-61. PubMed ID: 15287901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype dependent differential effects of interleukin-1beta and amyloid-beta on viability and cholinergic phenotype of T17 neuroblastoma cells.
    Bielarczyk H; Jankowska-Kulawy A; Gul S; Pawełczyk T; Szutowicz A
    Neurochem Int; 2005 Dec; 47(7):466-73. PubMed ID: 16122837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor and acetyl-L-carnitine evoked shifts in acetyl-CoA and cholinergic SN56 cell vulnerability to neurotoxic inputs.
    Szutowicz A; Bielarczyk H; Gul S; Zieliński P; Pawełczyk T; Tomaszewicz M
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):185-92. PubMed ID: 15558747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zinc on SN56 cholinergic neuroblastoma cells.
    Ronowska A; Gul-Hinc S; Bielarczyk H; Pawełczyk T; Szutowicz A
    J Neurochem; 2007 Nov; 103(3):972-83. PubMed ID: 17662047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between cholinergic phenotype and acetyl-CoA level in hybrid murine neuroblastoma cells of septal origin.
    Bielarczyk H; Tomaszewicz M; Madziar B; Cwikowska J; Pawełczyk T; Szutowicz A
    J Neurosci Res; 2003 Sep; 73(5):717-21. PubMed ID: 12929139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs.
    Szutowicz A; Bielarczyk H; Gul S; Ronowska A; Pawełczyk T; Jankowska-Kulawy A
    Metab Brain Dis; 2006 Sep; 21(2-3):149-61. PubMed ID: 16724269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of zinc on acetylcholine metabolism and viability of SN56 cholinergic neuroblastoma cells.
    Ronowska A; Dyś A; Jankowska-Kulawy A; Klimaszewska-Łata J; Bielarczyk H; Romianowski P; Pawełczyk T; Szutowicz A
    Neurochem Int; 2010 Jan; 56(1):143-51. PubMed ID: 19781588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-CoA and acetylcholine metabolism in nerve terminal compartment of thiamine deficient rat brain.
    Jankowska-Kulawy A; Bielarczyk H; Pawełczyk T; Wróblewska M; Szutowicz A
    J Neurochem; 2010 Oct; 115(2):333-42. PubMed ID: 20649840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-CoA metabolism in cholinergic neurons and their susceptibility to neurotoxic inputs.
    Szutowicz A; Tomaszewicz M; Jankowska A; Madziar B; Bielarczyk H
    Metab Brain Dis; 2000 Mar; 15(1):29-44. PubMed ID: 10885539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
    J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-Dependent Interactions between N-acetyl-L-Aspartate and Acetyl-CoA in Septal SN56 Cholinergic Cells Exposed to an Excess of Zinc.
    Zyśk M; Bielarczyk H; Gul-Hinc S; Dyś A; Gapys B; Ronowska A; Sakowicz-Burkiewicz M; Szutowicz A
    J Alzheimers Dis; 2017; 56(3):1145-1158. PubMed ID: 28106547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of lipopolysaccharide on energy metabolism in murine microglial N9 and cholinergic SN56 neuronal cells.
    Klimaszewska-Łata J; Gul-Hinc S; Bielarczyk H; Ronowska A; Zyśk M; Grużewska K; Pawełczyk T; Szutowicz A
    J Neurochem; 2015 Apr; 133(2):284-97. PubMed ID: 25345568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential toxicity of nitric oxide, aluminum, and amyloid beta-peptide in SN56 cholinergic cells from mouse septum.
    Bielarczyk H; Jankowska A; Madziar B; Matecki A; Michno A; Szutowicz A
    Neurochem Int; 2003 Mar; 42(4):323-31. PubMed ID: 12470706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons.
    Szutowicz A
    J Neurosci Res; 2001 Dec; 66(5):1009-18. PubMed ID: 11746431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-CoA metabolism in amprolium-evoked thiamine pyrophosphate deficits in cholinergic SN56 neuroblastoma cells.
    Bizon-Zygmańska D; Jankowska-Kulawy A; Bielarczyk H; Pawełczyk T; Ronowska A; Marszałł M; Szutowicz A
    Neurochem Int; 2011 Aug; 59(2):208-16. PubMed ID: 21672592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular redistribution of acetyl-CoA, the pivotal point in differential susceptibility of cholinergic neurons and glial cells to neurodegenerative signals.
    Szutowicz A; Bielarczyk H; Ronowska A; Gul-Hinc S; Klimaszewska-Łata J; Dyś A; Zyśk M; Pawełczyk T
    Biochem Soc Trans; 2014 Aug; 42(4):1101-6. PubMed ID: 25110009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of glutathione in nitric oxide donor toxicity to SN56 cholinergic neuron-like cells.
    Fass U; Panickar K; Williams K; Nevels K; Personett D; McKinney M
    Brain Res; 2004 Apr; 1005(1-2):90-100. PubMed ID: 15044069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lead on cholinergic SN56 neuroblastoma cells.
    Jankowska-Kulawy A; Gul-Hinc S; Bielarczyk H; Suszkiw JB; Pawełczyk T; Dyś A; Szutowicz A
    Acta Neurobiol Exp (Wars); 2008; 68(4):453-62. PubMed ID: 19112468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.